Neurologist - Movement Disorders, Kansas City, MO
Saint Luke’s Hospital of Kansas City is searching for a BC/BE, fellowship-trained, Movement Disorders Neurologist, at the level of Assistant or Associate Professor to join the Parkinson Disease and Movement Disorders Center in the Department of Neurology at Saint Luke’s Marion Bloch Neuroscience Institute (SLMBNI). Academic title available at the affiliated University of Missouri–Kansas City School of Medicine.
SLMBNI is a comprehensive, rapidly growing, well-endowed institution with specialists in neurology, neurosurgery, interventional neuroradiology, neurophysiology, neuro-oncology, neurootology, sleep medicine, pain medicine, psychiatry and physical medicine and rehabilitation working together on multiple campuses and through the network of affiliated hospitals. In 2013, the Neuroscience Institute moved to an 80,000 square feet of dedicated space for the Neurosciences, the result of a $330 million expansion and renovation of the hospital campus. The facility features an 18-bed neuro intensive care unit, four dedicated neurosurgical operating rooms, two neuroradiology interventional suites, a dedicated EEG monitoring unit, a full service neuro-diagnostics lab and three inpatient units for patients with neurologic disorders. In 2018, Saint Luke’s Hospital was ranked number 44 in Neurology and Neurosurgery by the U.S. News and World Report.
Hospital employment package includes an excellent compensation and benefits plan. All inquiries will be confidential.
About Saint Luke’s Marion Bloch Neuroscience Institute (SLMBNI)
Saint Luke’s Marion Bloch Neuroscience Institute (SLMBNI), a member of Saint Luke’s Health System, is a global leader in utilizing both drug and mechanical interventions to block and reverse the permanent and debilitating effects of ischemic strokes. Its legacy of innovation began in 1993 when doctors performed one of the world’s first intra-arterial stroke reversal procedures. Since then, Saint Luke’s specialists have continued to pioneer new stroke treatments and reverse stroke’s debilitating effects for thousands of patients, and is one of the world’s most experienced and prolific leaders in the use of Tissue Plasminogen Activator (t-PA) clot-busting medication for treatment of ischemic stroke. SLMBNI, headquartered in Kansas City, Missouri, brings together a team of the country’s most accomplished neurologists, neurosurgeons, neurointerventionalists, and other specialists in neurological care, to provide a comprehensive treatment center for the most complex neurological issues, such as stroke, epilepsy, brain tumors, facial pain, Parkinson’s disease, Alzheimer’s, headaches, aneurysms, and the latest in minimally invasive spinal surgical techniques. SLMBNI’s advancements in neurology have made it a national leader in neurological treatment and care.
About Saint Luke’s Hospital
Saint Luke’s Hospital of Kansas City has 611 beds and is one of the largest tertiary care hospitals in the region. Its network of more than 600 physicians represents more than 60 medical specialties. Saint Luke’s Hospital is a primary teaching hospital for the University of Missouri–Kansas City School of Medicine. It is a winner of the Malcolm Baldrige National Quality Award; is recognized by U.S. News & World Report in numerous areas; and is nationally known for innovation, research, and patient care.
About Saint Luke’s Health System
Saint Luke’s Health System consists of 10 area hospitals and campuses as well as multiple primary and specialty care practices, and provides a range of inpatient, outpatient, and home care services. Founded as a faith-based, not-for-profit organization, our mission includes a commitment to the highest levels of excellence in health care and the advancement of medical research and education. The health system is an aligned organization in which the physicians and hospitals assume responsibility for enhancing the physical, mental, and spiritual health of people in the metropolitan Kansas City area and the surrounding region.